Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma (original) (raw)
Glioblastoma: Therapeutic challenges, what lies ahead
Luciana Romão
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
View PDFchevron_right
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas
Johan Kros
Neuro-oncology, 2015
View PDFchevron_right
Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients
Nikola Tanic
PLoS ONE, 2013
View PDFchevron_right
Glioma Cell Biology
Aleksi Šedo
2014
View PDFchevron_right
EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma
Tahani Nageeti
Oncology Letters, 2020
View PDFchevron_right
Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas
Koichi Ichimura
Journal of Molecular Medicine, 2005
View PDFchevron_right
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
Rolf Bjerkvig
Acta Neuropathologica, 2013
View PDFchevron_right
Association between Functional EGF+61 Polymorphism and Glioma Risk
Sandra Costa
Clinical Cancer Research, 2007
View PDFchevron_right
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Sek Kong
Nature, 2008
View PDFchevron_right
The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis
Johan Kros
WFNOS 2022 Abstract Book, 2022
View PDFchevron_right
Prognostic genetic markers in malignant gliomas
Stefan Linsler
Romanian …
View PDFchevron_right
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
Johan Kros
Neuro-oncology, 2021
View PDFchevron_right
Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival
Adwait Sathe
Journal of Neuropathology & Experimental Neurology, 2019
View PDFchevron_right
Detection of epidermal growth factor receptor mutations in circulating tumor DNA: reviewing BENEFIT clinical trial
luis raez
Journal of Thoracic Disease, 2018
View PDFchevron_right
Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain
July Paez
PLOS Medicine, 2006
View PDFchevron_right
Imaging guidelines and findings of extracranial glioblastoma
Pamela Schaefer
Journal of Neuro-Oncology, 2014
View PDFchevron_right
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
Oleg Kit
International Journal of Oncology
View PDFchevron_right
Prognosis in Idh-Mutant and Idh-Wild Type Glioblastoma
hatice özer
Cumhuriyet Medical Journal, 2021
View PDFchevron_right
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients
Clara Mayo
Annals of Oncology, 2005
View PDFchevron_right
Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings
Amila Čeliković
Brain Sciences, 2023
View PDFchevron_right
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Timothy Van Meter
Cancer Cell, 2012
View PDFchevron_right
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer
Lorenzo Daniele
Journal of Thoracic Oncology, 2009
View PDFchevron_right
Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma
Simona Lamba
Cancer Research, 2007
View PDFchevron_right
Frequency of and variables associated with the EGFR mutation and its subtypes
Kunihiko Kobayashi
International Journal of Cancer, 2010
View PDFchevron_right
Epigenomic perturbation of novelEGFRenhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide
Itzel Nissen
bioRxiv (Cold Spring Harbor Laboratory), 2023
View PDFchevron_right
Review: On TRAIL for malignant glioma therapy?
Wijnand Helfrich
Neuropathology and Applied Neurobiology, 2010
View PDFchevron_right
Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses
Koichi Ichimura
Neuro-Oncology, 2010
View PDFchevron_right
Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels
HERMINIO JOSE TAO
PLoS ONE, 2012
View PDFchevron_right
Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
Irene Slavc
Cancer Discovery, 2020
View PDFchevron_right
Acidic and Basic Fibroblast Growth Factors Are Present in Glioblastoma Multiforme and Normal Brain
Robert Elde
Annals of the New York Academy of Sciences, 1991
View PDFchevron_right
Angiocentric glioma: the infiltrative glioma with ependymal differentiation
Kemal Yücesoy
Turkish Journal of Pathology, 2013
View PDFchevron_right
The vascular endothelial growth factor genes expression in glioma U87 cells is dependent from ERN1 signaling enzyme function
Serhiy komisarenko
Advances in Biological Chemistry, 2012
View PDFchevron_right
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation
Anna N Cvrljevic - Lipsanen
Cancers, 2011
View PDFchevron_right
Insulin-like growth factor binding protein 2 promotes glioma development and progression
J. Celestino
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme
Erin Balcom
Journal of Neuro-Oncology, 2019
View PDFchevron_right